Status:

COMPLETED

Bronx A1c: Bring it Down for Health

Lead Sponsor:

Albert Einstein College of Medicine

Collaborating Sponsors:

New York City Department of Health and Mental Hygiene

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

To address and reduce population-attributable risk due to elevated HbA1c, the New York City Department of Health and Mental Hygiene (DOHMH) developed an innovative HbA1c registry, which requires all m...

Detailed Description

Metabolic control of diabetes, measured by hemoglobin A1c (HbA1c), reduces the risk of microvascular complications. Health care providers frequently do not meet standards for managing HbA1c and indivi...

Eligibility Criteria

Inclusion

  • Subjects will be those patients with diabetes who speak English and/or Spanish and reside in the South Bronx.
  • Subjects will be adults, \> 18 years, with diabetes, who become part of the NYC registry by virtue of having a reported HbA1c \>7% to the DOHMH.
  • The sampling frame for this study comprises virtually all adults with diabetes in the South Bronx.

Exclusion

  • Age \< 18 years
  • A1c \< = 7 %
  • Refuses informed consent and HIPAA consent
  • Cognitive dysfunction as assessed by telephone
  • Does not read or speak English or Spanish
  • No diabetes

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2012

Estimated Enrollment :

941 Patients enrolled

Trial Details

Trial ID

NCT00797888

Start Date

September 1 2008

End Date

June 1 2012

Last Update

June 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

New York City Department of Health & Mental Hygiene

New York, New York, United States, 10461